This website uses cookies to enhance the user experience.
S

SALMO PHARMA AS916 266 081

Research
Limited company
Solfjellsjøen 8827 DØNNA, Norge

SALMO PHARMA AS

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Organization

Chairman of the board
Years since formation
10 years
since Nov 19, 2015
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
2
companies
Belongs to group of

Financials

Total operating income 2024
10,612,217
NOK
Annual total result 2024
7,076,990
NOK
Total equity 2024
12,931,990
NOK
Last update: Jul 30, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
40 %
indirectly

Board

NameRoleShares
Chairman
40 %
indirectly
Board Member
40 %
indirectly
Board Member
7.14 %
indirectly
Alternate Member-
Alternate Member-
Alternate Member
6.29 %
indirectly

Others

NameRoleShares
H
HELGELAND REVISJON AS
Auditor-
D
DIN BEDRIFTSPARTNER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
40 %
indirectly
Board Member
40 %
indirectly
Board Member
7.14 %
indirectly
-
6.57 %
indirectly
Alternate Member
6.29 %
indirectly
Last update: Jan 17, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
N
NORVET AS
Ordinary shares
80
80 %
Å
ÅKERØYA AS
Ordinary shares
20
20 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 8,208,383
    Operating profit 2024: NOK 3,255,901
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
10,612,217
41,024
154,924,192
103,286,327
Annual Total Result
7,076,990
-1,265,325
23,000,049
23,794,472
Total assets
13,461,116
36,482,933
58,343,355
86,750,232
Total liabilities
529,126
10,627,933
31,223,030
82,629,955
Total equity
12,931,990
25,855,000
27,120,325
4,120,277

P&L

Year2024202320222021
Total operating income
10,612,217
41,024
154,924,192
103,286,327
Total operating costs
3,266,100
3,817,934
127,112,742
74,255,026
Operating result
7,346,117
-3,776,910
27,811,450
29,031,301
Financial income/costs
1,353,966
1,197,843
335,323
134,689
Profit before tax
8,700,082
-2,579,067
28,146,773
29,165,989
Total tax & extraordinary income/cost
1,623,092
-1,313,742
5,146,724
5,371,517
Annual Total Result
7,076,990
-1,265,325
23,000,049
23,794,472

Balance overview

Year2024202320222021
Total fixed assets
29,061
1,385,062
185,750
0
Total current assets
13,432,055
35,097,871
58,157,605
86,750,232
Total assets
13,461,116
36,482,933
58,343,355
86,750,232
Short term debt
529,126
10,627,933
31,217,800
74,242,411
Long term debt
0
0
5,230
8,387,544
Total liabilities
529,126
10,627,933
31,223,030
82,629,955
Contributed capital
3,155,714
3,155,714
3,155,714
3,155,714
Retained earnings
9,776,276
22,699,286
23,964,611
964,563
Total equity
12,931,990
25,855,000
27,120,325
4,120,277
Total equity and liabilities
13,461,116
36,482,933
58,343,355
86,750,232

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering